chevron_leftBack
As of 24 April 2025, America Great Health has a market cap of $106.01M USD, ranking #20405 globally and #3327 in the United States. It ranks #2031 in the Healthcare sector, and #618 in the Biotechnology industry.
Key Stats
Market Cap
$106.01MUSD
Enterprise Value
$109.54MUSD
Revenue (TTM)
$420.75KUSD
EBITDA (TTM)
-$730.48KUSD
Net Income (TTM)
-$1.15MUSD
EBITDA Margin
-174%
Profit Margin
-274%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Mike Wang
open_in_new
Employees
5
Website
aaghus.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 100% | 780% | 780% | 4K% | 267% | 340% |
Upcoming Earnings
Earnings Date
Mon, Jun 2
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
AAGH
ISIN: US02365T1016
Shares Out.:
Shares Outstanding:
21.203B1
Shares Float:
19.063B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0050 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About America Great Health
America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California.
